Esperion Therapeutics (NASDAQ:ESPR)

CAPS Rating: 2 out of 5

Caps

How do you think ESPR will perform against the market?

Add Stock to CAPS Watchlist

All Players

65 Outperform
13 Underperform
 

All-Star Players

14 Outperform
3 Underperform
 

Wall Street

2 Outperform
1 Underperform
 

Top ESPR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.86)
Submitted July 31, 2015

I'm way out of my depth with Esperion. They've clearly got an active drug in ETC-1002 with a great shot at strong phase III data and FDA approval. The question at this point is whether the commercial potential of ETC-1002 justifies the 1.8B valuation… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

ESPR VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ESPR.

Recs

0
Member Avatar TMFEBCapital (62.30) Submitted: 5/5/2017 10:50:14 AM : Outperform Start Price: $34.26 ESPR Score: +22.02

Yes, this company is losing money, and yes, it won't have data on its cholesterol lowering drug until next year, but the market opp - if successful - could exceed $1 billion, given an addressable patient population of about 3 million Americans who aren't adequately controlled by statins. The use of bempodeic acid as an adjunct to top sellers like Lipitor could make this an easy drug to commecialize, and given that ESPR founder is the same person who developed Lipitor (the best selling drug ever), I'm not going to bet against him.

Recs

0
Member Avatar DeathStock (96.53) Submitted: 4/10/2017 2:21:00 PM : Outperform Start Price: $10.91 ESPR Score: +298.70

Let's take it to $100

I'm living on the air in Cincinnati, Cincinnati WKRP.

https://www.youtube.com/watch?v=zgrVP_J0BHk

Recs

0
Member Avatar adamicius (< 20) Submitted: 3/14/2017 5:04:05 PM : Outperform Start Price: $30.62 ESPR Score: +37.42

targeted therapies to lower LDL cholesterol for patients not adequately treated with current therapies. That's a huge potential market, IF they can deliver.

Leaderboard

Find the members with the highest scoring picks in ESPR.

Score Leader

TerryHoodSr

TerryHoodSr (56.75) Score: +648.65

The Score Leader is the player with the highest score across all their picks in ESPR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
superstar2 99.52 7/6/2016 Outperform 5Y $10.33 +346.76% +28.45% +318.31 0 Comment
stereotyp72 62.13 1/24/2017 Outperform 5Y $11.00 +319.55% +18.89% +300.66 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. DeathStock 96.53 7/26/2016 Outperform 5Y $10.91 +323.01% +24.31% +298.70 1 Comment
gunda7907 < 20 12/11/2013 Outperform 5Y $12.51 +268.90% +49.94% +218.96 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hayrettin 70.60 2/3/2017 Outperform 5Y $14.98 +208.08% +17.39% +190.68 0 Comment
mgelinas 32.30 4/28/2014 Outperform 5Y $14.21 +224.77% +43.90% +180.87 0 Comment
dollarsandcents1 < 20 1/19/2016 Outperform 5Y $14.31 +222.50% +41.69% +180.81 0 Comment
portefeuille2 98.78 9/17/2014 Outperform 5Y $15.85 +191.17% +34.06% +157.10 0 Comment
MtnDuck 50.80 3/31/2016 Outperform 3Y $16.46 +180.38% +30.72% +149.66 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. ababrmon 73.36 10/24/2013 4/14/2015 Outperform 1Y $15.35 +200.65% +53.90% +146.75 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCitigroup 91.53 8/17/2018 Outperform NS $49.97 -7.64% -5.17% -2.48 0 Comment
TrackJimCramer 85.19 2/27/2017 Underperform 3W $25.87 +78.39% +13.52% -64.88 0 Comment
TrackJimCramer 85.19 1/6/2015 Outperform 3W $43.37 -40.35% +18.66% -59.01 2/27/2017 @ $25.87 0 Comment
TrackCreditSuiss 88.59 7/23/2013 Outperform NS $17.40 +165.23% +58.52% +106.71 0 Comment

Advertisement